Mutations in Bri2 result in proteolytic release of amyloidogenic peptides (ABri and ADan) and eventually development of familial British or Danish dementias (FBD/FDD), which share clinical and pathological characteristics with AD22, 25. This evidence concerns the gene ITM2B and dementia.